Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy
- 1 July 1999
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 48 (1) , 63-70
- https://doi.org/10.1046/j.1365-2125.1999.00967.x
Abstract
Aims A pharmacokinetic/pharmacodynamic model, with Bayesian parameter estimation, was used to retrospectively predict the daily International Normalized Ratios (INRs) and the maintenance doses during the initiation of warfarin therapy in 74 inpatients. Methods INRs and maintenance doses predicted by the model were compared with the actual INRs and the eventual maintenance dose. Cases with drugs or medical conditions interacting with warfarin or receiving concurrent heparin therapy were not excluded. As the study was retrospective, model predictions of the maintenance dose were not those that were administered. Mean prediction error (MPE) and percentage absolute prediction errors (PAPE) were used to assess the model predictions. Results INR MPE ranged from −0.07 to 0.06 and median PAPE from 10% to 20%. Dose MPE ranged from −0.7 to 0.17 mg and median PAPE from 16.7% to 37.5%. Accurate and precise dose predictions were obtained after 3 or more INR feedback’s. Conclusions This study shows that the model can accurately predict daily INRs and the maintenance dose in this sample of cases. The model can be incorporated into computer decision-support systems for warfarin therapy and may lead to improvement in the initiation of warfarin therapy.Keywords
This publication has 37 references indexed in Scilit:
- System identification of a non-classically damped linear systemComputers & Structures, 1993
- Audit of start of anticoagulation treatment in inpatients.Journal of Clinical Pathology, 1993
- Bayesian Parameter Estimation and Population PharmacokineticsClinical Pharmacokinetics, 1992
- Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.Journal of Clinical Pathology, 1990
- Clinical Pharmacokinetics and Pharmacodynamics of WarfarinClinical Pharmacokinetics, 1986
- Population pharmacokinetics of racemic warfarin in adult patientsJournal of Pharmacokinetics and Biopharmaceutics, 1985
- Flexible induction dose regimen for warfarin and prediction of maintenance dose.BMJ, 1984
- Comparison of the bioavailabilities and anticoagulant activities of two warfarin formulationsBritish Journal of Haematology, 1982
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977